Division of Nephrology, Department of Internal Medicine, Ewha Womans University School of Medicine, Ewha Medical Research Center, Seoul, South Korea.
J Hypertens. 2010 Jun;28(6):1234-42.
Oxidative stress is known to be a major mechanism of endothelial dysfunction, which plays a key role in the development of cardiovascular disease. Although uric acid is one of the most important antioxidants, recent studies have suggested that uric acid may have a causal role in endothelial dysfunction. In order to understand the paradoxical association of uric acid with oxidative stress and vascular disease, we investigated whether uric acid induced oxidative stress in human vascular endothelial cells. We also examined whether uric acid-induced changes in redox status were related to aging and death of endothelial cells or an activation of local renin-angiotensin system, another mediator of endothelial dysfunction.
Endothelial senescence and apoptosis were evaluated by senescence-associated beta-galactosidase staining and annexin V-propidium iodide staining in primary isolated human umbilical vein endothelial cells (HUVECs). Production of reactive oxygen species was assessed by dichlorofluorescein diacetate staining. mRNA expression of angiotensinogen, angiotensin-converting enzyme and the receptors of angiotensin II was evaluated by real-time PCR, and angiotensin II levels were measured in uric acid-stimulated HUVECs.
Uric acid-induced senescence and apoptosis in HUVECs at concentrations more than 6 and 9 mg/dl, respectively. Uric acid-induced alterations in cell proliferation, senescence and apoptosis were blocked by probenecid, enalaprilat or telmisartan. Uric acid significantly increased production of reactive oxygen species beginning at 5 min, and uric acid-induced senescence and apoptosis of HUVECs were ameliorated by N-acetylcysteine or tempol. Uric acid also upregulated the expression of angiotensinogen, angiotensin-converting enzyme and angiotensin II receptors and increased angiotensin II levels, which was ameliorated with tempol.
Uric acid-induced aging and death of human endothelial cells are medicated by local activation of oxidative stress and the renin-angiotensin system, which provides a novel mechanism of uric acid-induced endothelial dysfunction. Therapies targeting uric acid maybe beneficial in cardiovascular disease.
氧化应激是内皮功能障碍的主要机制之一,在心血管疾病的发展中起着关键作用。尽管尿酸是最重要的抗氧化剂之一,但最近的研究表明,尿酸可能在内皮功能障碍中起因果作用。为了了解尿酸与氧化应激和血管疾病之间的矛盾关联,我们研究了尿酸是否会在人血管内皮细胞中诱导氧化应激。我们还检查了尿酸引起的氧化还原状态变化是否与内皮细胞衰老和死亡或局部肾素-血管紧张素系统的激活有关,后者也是内皮功能障碍的另一种介质。
通过衰老相关β-半乳糖苷酶染色和 Annexin V-碘化丙啶染色评估原代分离的人脐静脉内皮细胞(HUVEC)中的内皮衰老和凋亡。通过二氯荧光素二乙酸染色评估活性氧的产生。通过实时 PCR 评估血管紧张素原、血管紧张素转换酶和血管紧张素 II 受体的 mRNA 表达,并在尿酸刺激的 HUVEC 中测量血管紧张素 II 水平。
尿酸在浓度超过 6 和 9 mg/dl 时分别诱导 HUVEC 衰老和凋亡。丙磺舒、依那普利或替米沙坦阻断尿酸诱导的细胞增殖、衰老和凋亡改变。尿酸在 5 分钟开始时显著增加活性氧的产生,尿酸诱导的 HUVEC 衰老和凋亡通过 N-乙酰半胱氨酸或替莫唑胺得到改善。尿酸还上调了血管紧张素原、血管紧张素转换酶和血管紧张素 II 受体的表达,并增加了血管紧张素 II 水平,替莫唑胺可改善这一水平。
尿酸诱导的人内皮细胞衰老和死亡是由局部氧化应激和肾素-血管紧张素系统的激活介导的,这为尿酸诱导的内皮功能障碍提供了一种新的机制。针对尿酸的治疗方法可能对心血管疾病有益。